NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Doffo J, Bamopoulos SA, Kose H, Orben F, et al. Proc Natl Acad Sci U S A 2022;119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Doffo J, Bamopoulos SA, Kose H, Orben F, et al. NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Proc Natl Acad Sci U S A 2022;119.
PMID: 35197278